ADARx
ADARx is developing a RNA targeting platform focused on genetic, cardiometabolic and central nervous system diseases
1
Funding Rounds
$75.0m
Money raised
Overview
ADARx is developing a RNA targeting platform focused on genetic, cardiometabolic and central nervous system diseases
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company ADARx has raised a total of $75m in funding over 1 rounds.
Key Insights:
- ADARx Series B round, September 8, 2021: $75m
ADARx Series B round, September 8, 2021
$75m
Industries
ADARx is active in the following industries: